Ophthalmology · Philadelphia, PA
NPI
1437157799
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
840 Walnut St Ste 920
Philadelphia, PA, 19107
Phone (215) 928-3180
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
1,361 services
Medicare patients, 2024
529
Average age 75
Drug cost, 2024
$950K
3,118 prescriptions
Company payments, 2025
$1,279
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Rapuano was code 99213 (office e&m - established), 433 times for 306 patients. In total Christopher J Rapuano billed 1,361 services in 37 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 433 | 306 | $66.19 | $29K |
| 99214 Office E&M - Established | Office | 403 | 237 | $96.67 | $39K |
| 76514 Ultrasound - Nonspecific | Office | 157 | 112 | $8.22 | $1,291 |
| 92025 Test - Miscellaneous | Office | 107 | 87 | $25.94 | $2,775 |
| 99204 Office E&M - New | Office | 83 | 83 | $120.79 | $10K |
| 67820 Eye | Office | 29 | 19 | $13.61 | $395 |
| 92286 Standard X-ray | Office | 28 | 27 | $26.19 | $733 |
| 68761 Eye | Office | 12 | 11 | $121.67 | $1,460 |
By year: 2022 $138K for 1,210 services; 2023 $128K for 1,334 services; 2024 $122K for 1,361 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Rapuano prescribed most often to Medicare patients was Erythromycin (Erythromycin Base), with 766 prescriptions and refills. In total Christopher J Rapuano wrote 3,118 Medicare prescriptions that cost $950K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erythromycin Erythromycin Base | 766 | 888 | 214 | $13K |
| Prednisolone Acetate Generic | 525 | 874 | 178 | $26K |
| Restasis Cyclosporine | 205 | 437 | 75 | $255K |
| Valacyclovir Valacyclovir Hcl | 181 | 328 | 57 | $10K |
| Loteprednol Etabonate Generic | 172 | 330 | 60 | $34K |
| Moxifloxacin Moxifloxacin Hcl | 117 | 135 | 64 | $4,845 |
| Cyclosporine Generic | 85 | 206 | 34 | $56K |
| Ofloxacin Generic | 81 | 90 | 44 | $1,407 |
| Acyclovir Generic | 78 | 147 | 15 | $1,274 |
| Bacitracin-Polymyxin Bacitracin/Polymyxin B Sulfate | 77 | 81 | 23 | $1,583 |
| Brimonidine Tartrate Generic | 74 | 144 | 26 | $4,488 |
| Latanoprost Generic | 59 | 110 | 21 | $550 |
| Xiidra Lifitegrast | 46 | 81 | 13 | $54K |
| Fluorometholone Generic | 45 | 88 | 22 | $4,275 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 41 | 97 | 20 | $744 |
Brand drugs: 1,333 claims; generic drugs: 1,785 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher J Rapuano $1,279 ($1,279 in general payments such as food, travel and fees) from 13 companies. The largest payer was Dompe US, Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Dompe US, Inc. | 7 | $296 |
| Glaukos Corporation GKOS | 1 | $196 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $192 |
| Biotissue Holdings Inc. | 2 | $177 |
| Samsara Vision | 1 | $82.83 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $73.79 |
| Harrow Eye, LLC | 3 | $65.79 |
| Alcon Vision LLC ALC | 2 | $50.63 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $44.49 |
| Mallinckrodt Hospital Products Inc. | 1 | $39.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.